Omeprazole Dosing for a 3-Year-Old Child
For a 3-year-old child weighing 14-15 kg with symptomatic GERD or erosive esophagitis, administer omeprazole 10 mg once daily before meals. 1, 2
Standard FDA-Approved Dosing
The FDA-approved weight-based dosing for children aged 2-16 years is straightforward:
Since your patient weighs 14-15 kg, they fall squarely in the 10 mg once daily category for both symptomatic GERD and erosive esophagitis treatment. 1, 2
Treatment Duration and Monitoring
- Initial treatment course: 4-8 weeks for erosive esophagitis 2
- For symptomatic GERD without esophagitis: up to 4 weeks 2
- If inadequate response after 8 weeks, an additional 4-week course may be considered 2
Dose Escalation for Refractory Cases
If the standard 10 mg daily dose proves insufficient (which occurs in approximately 50% of cases requiring higher doses), consider escalation: 3, 4
- Escalate to 0.7-1.4 mg/kg/day in divided doses for severe or refractory GERD 1, 3
- For a 14-15 kg child, this translates to approximately 10-20 mg daily total 4
- Some children may require up to 2.8 mg/kg/day (approximately 40 mg daily for this weight) 1, 4
For eosinophilic esophagitis specifically, use 1 mg/kg twice daily (approximately 15 mg twice daily for this child, maximum 40 mg/day total) 1
Administration Instructions
For children unable to swallow capsules: 2
- Open the capsule and mix pellets with 1 tablespoon of applesauce (not hot, soft enough to swallow without chewing)
- Swallow immediately with cool water
- Do not chew or crush the pellets
- Do not save mixture for later use
Alternatively, a compounded 6 mg/mL suspension can be prepared by a retail pharmacy. 1
Important Clinical Considerations
Common pitfalls to avoid:
- Do not extrapolate adult dosing to children—always use weight-based pediatric dosing 1
- Administer before meals for optimal efficacy 2
- Antacids may be used concomitantly without interaction 2
Monitoring for adverse effects: 1, 5
- Common side effects include headaches, diarrhea, constipation, and nausea (up to 14% of children) 5
- Long-term use (>2.5 years) may cause enterochromaffin cell hyperplasia in up to 50% of children 1
- Elevated gastrin levels occur but clinical significance in children remains unclear 6
Evidence quality note: While the FDA label and American Academy of Pediatrics guidelines provide clear weight-based dosing, the supporting research evidence is of very low certainty, with most studies showing omeprazole may or may not provide benefit over placebo in infants. 7 However, in older children with documented erosive esophagitis or severe symptoms, clinical experience supports efficacy at these doses. 8, 6